NGM Biopharmaceuticals, Inc.
Methods of using compositions comprising variants of FGF19 polypeptides for reducing bile acid synthesis in a subject having cirrhosis

Last updated:

Abstract:

The invention relates to methods of using variants of fibroblast growth factor 19 (FGF19) for reducing bile acid synthesis in a subject having cirrhosis.

Status:
Grant
Type:

Utility

Filling date:

21 Feb 2019

Issue date:

31 Aug 2021